Critical evaluation of agents used in the treatment and prevention of cytomegalovirus infection in immunocompromised patients.
作者信息
Meyers J D
机构信息
Program in Infectious Diseases, Fred Hutchinson Cancer Research Center, Seattle, Washington 98104.
出版信息
Transplant Proc. 1991 Jun;23(3 Suppl 3):139-42, discussion 142-3.
PMID:1648819
Abstract
摘要
相似文献
1
Critical evaluation of agents used in the treatment and prevention of cytomegalovirus infection in immunocompromised patients.对免疫功能低下患者治疗和预防巨细胞病毒感染所用药物的批判性评价。
Transplant Proc. 1991 Jun;23(3 Suppl 3):139-42, discussion 142-3.
2
Treatment of cytomegalovirus pneumonia after bone marrow transplantation with cytomegalovirus immunoglobulin combined with ganciclovir.用巨细胞病毒免疫球蛋白联合更昔洛韦治疗骨髓移植后的巨细胞病毒肺炎。
Bone Marrow Transplant. 1989 Mar;4(2):187-9.
3
[Incidence, therapy and prevention of cytomegalovirus disease after bone marrow transplantation].
Med Klin (Munich). 1992 Oct;87 Suppl 1:30-8.
4
5
Cytomegalovirus infection and prophylaxis in heart transplantation.
Transplant Proc. 1993 Feb;25(1 Pt 2):1427-8.
6
7
Treatment of CMV infections and disease in transplantation.移植中巨细胞病毒感染和疾病的治疗。
Transplant Proc. 1991 Jun;23(3 Suppl 3):126-9, discussion 129-30.
8
9
Should all CMV infections after bone marrow transplantation be treated?所有骨髓移植后的巨细胞病毒感染都应该进行治疗吗？
Bone Marrow Transplant. 1991;7 Suppl 2:47.
引用本文的文献
1
The conditions of primary infection define the load of latent viral genome in organs and the risk of recurrent cytomegalovirus disease.原发性感染的情况决定了器官中潜伏病毒基因组的负荷以及巨细胞病毒复发疾病的风险。
J Exp Med. 1994 Jan 1;179(1):185-93. doi: 10.1084/jem.179.1.185.
Zotero 插件